| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Citius Pharmaceuticals Inc (NASDAQ: CTXR)
CTXR Technical Analysis
5
| As on 25th Nov 2024 CTXR STOCK Price closed @ 0.13 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.84 & Strong Sell for SHORT-TERM with Stoploss of 1.10 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CTXRSTOCK Price
| Open | 0.18 | Change | Price | % |
| High | 0.18 | 1 Day | 0.00 | 0.00 |
| Low | 0.13 | 1 Week | -0.18 | -58.06 |
| Close | 0.13 | 1 Month | -0.27 | -67.50 |
| Volume | 146943285 | 1 Year | -1.09 | -89.34 |
| 52 Week High 1.36 | 52 Week Low 0.17 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 136.02 | -4.18% |
| SMCI | 38.41 | 15.87% |
| CTXR | 0.13 | 0.00% |
| QUBT | 7.70 | 26.23% |
| MARA | 26.42 | 9.63% |
| LMDX | 0.02 | 0.00% |
| PLUG | 2.20 | 14.58% |
| TSLA | 338.59 | -3.96% |
| SAVA | 4.29 | -83.80% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CTXR Daily Charts |
CTXR Intraday Charts |
Whats New @ Bazaartrend |
CTXR Free Analysis |
|
|
CTXR Important Levels Intraday
| RESISTANCE | 0.23 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.18 |
| RESISTANCE | 0.16 |
| SUPPORT | 0.10 |
| SUPPORT | 0.08 |
| SUPPORT | 0.06 |
| SUPPORT | 0.03 |
CTXR Forecast November 2024
| 4th UP Forecast | 0.94 |
| 3rd UP Forecast | 0.68 |
| 2nd UP Forecast | 0.52 |
| 1st UP Forecast | 0.36 |
| 1st DOWN Forecast | -0.1 |
| 2nd DOWN Forecast | -0.26 |
| 3rd DOWN Forecast | -0.42 |
| 4th DOWN Forecast | -0.68 |
CTXR Weekly Forecast
| 4th UP Forecast | 0.34 |
| 3rd UP Forecast | 0.27 |
| 2nd UP Forecast | 0.23 |
| 1st UP Forecast | 0.19 |
| 1st DOWN Forecast | 0.07 |
| 2nd DOWN Forecast | 0.03 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.08 |
CTXR Forecast2024
| 4th UP Forecast | 2.62 |
| 3rd UP Forecast | 1.82 |
| 2nd UP Forecast | 1.33 |
| 1st UP Forecast | 0.83 |
| 1st DOWN Forecast | -0.57 |
| 2nd DOWN Forecast | -1.07 |
| 3rd DOWN Forecast | -1.56 |
| 4th DOWN Forecast | -2.36 |
Citius Pharmaceuticals Inc ( NASDAQ USA Symbol : CTXR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CTXR Business Profile
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing four proprietary products, including Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. Address: 11 Commerce Drive, Cranford, NJ, United States, 07016
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service